New: Maxis AI Workforce now live across clinical operations.Learn more →

Maxis AI — THE FIRST AI WORKFORCE IN CLINICAL TRIALS
For Heads of Biostatistics

Supervised AI Execution for Biostatistics Teams

Cut database-to-submission timelines without compromising statistical rigor.

A Day in the Life of a Head of Biostatistics

Three studies are heading toward database lock in the same quarter. Programmers are deep in SDTM mapping. Statisticians are reviewing draft TLFs. A regulatory question landed overnight that requires a re-run with two days notice.

The science is clear. The bottleneck is the volume of repetitive, validated work standing between the team and submission. Every cycle still depends on senior hands.

Maxis AI gives the function structured throughput — without compromising validation or the audit trail.

08:00Daily Standup
11:30Risk Review
14:00CRO Sync
16:45Board Briefing

Human-in-the-loop validation · Audit traceability · Governed execution

Pressures

The Pressures Biostatistics Leaders Carry Every Day

Programming Demand At Scale

As trials scale, programming demand grows faster than skilled headcount — repetitive mapping and validation cycles consume senior time.

Submission Timeline Risk

Documentation and re-validation cycles extend submission timelines, while late-stage findings disrupt critical-path plans.

Tooling Without Leverage

Investment in tools rarely converts into operational leverage; senior statisticians remain stuck in repetitive execution.

The constraint isn't statistical talent — it's repeatable, governed execution capacity around it.

Industry Reality

Industry Reality

  • Trial complexity drives larger, denser datasets across more sources.
  • Submission packages require deeper documentation and traceability.
  • Validation expectations are non-negotiable across regions.
  • Statistical programming talent is scarce and difficult to scale.
  • Re-runs after database lock create disproportionate risk.

Biostatistics is being asked to deliver more — faster — under stricter validation.

How Maxis AI Is Built for Biostatistics

Maxis AI deploys supervised agents inside statistical programming workflows — SDTM/ADaM preparation, TLF generation, reconciliation and submission readiness. Validation checkpoints and audit logs are preserved end-to-end.

Senior statisticians stop spending their day on mapping and formatting and return to analysis, interpretation and review. Every output remains traceable and inspection-ready.

How it Works

From Pain to Outcome: How Maxis AI Works for You

Repetitive SDTM/ADaM mapping consumes senior programming time.

Supervised mapping agents with continuous validation.

Faster, standardized dataset preparation under audit traceability.

Manual TLF generation slows submission cycles.

AI-assisted TLF generation aligned to defined templates.

Compressed cycle from database lock to submission package.

Documentation overhead extends timelines.

Auto-captured action logs and validation traces.

Submission-ready documentation produced as a byproduct of execution.

Late-stage findings disrupt critical-path plans.

Continuous reconciliation across data sources.

Earlier surfacing of issues and fewer late-stage re-runs.

Senior statisticians stuck in repetitive programming.

Agent execution under statistician supervision.

Senior talent focused on analysis, not formatting.

Case Study

Reduced Interim Analysis Turnaround from 3 Weeks to 2 Days

When 70–80% of programming effort was tied to SDTM/ADaM mapping and TFL generation, biometrics delivery slowed. Learn how execution capacity was restored across concurrent trials.

45%

Faster Database-to-Submission

3x

Programming Throughput

100%

Validation Preserved

0

Workflow Disruption

FAQ

All You Need to Know

Supervised agents handle repetitive mapping, validation and TLF generation — reducing manual cycles while preserving validation checkpoints and audit logs.

Yes. Validation, documentation and audit logs remain intact end-to-end. Maxis AI strengthens — never bypasses — the validation framework.

No. Maxis AI integrates within existing programming environments and validation frameworks.

Yes. As data volume and complexity increase, supervised automation strengthens consistency and predictability.

SDTM/ADaM preparation, TLF generation and the database-lock-to-submission cycle.

Looking for Agentic AI for clinical trials?

Explore the Agentic AI Platform.

See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.